3 infants dead after bacterial infection at Pa. hospital

The hospital said all of the babies had been born prematurely


A Pennsylvania hospital is trying to determine the source of a waterborne germ that appears to have infected at least eight infants in the neonatal intensive care unit, three of whom have died, according to an article on the Today website.

Geisinger Medical Center in Danville is sending very premature newborns and some expectant mothers to other facilities while officials investigate.

Four babies have recovered from an infection caused by the Pseudomonas bacterium, and one is still being treated with antibiotics.

Cultures of the water supply and surfaces inside the neonatal intensive care unit, where all the infections occurred, tested negative for Pseudomonas.

Read the article.

 



October 10, 2019


Topic Area: Infection Control


Recent Posts

The Future of Healthcare Facility Construction Projects

Brian Cowperthwaite highlights the invisible work that impacts everyone who walks through a healthcare facility.


Arnprior Regional Health Upgrades Building Controls to Improve IEQ

Case study: They wanted to improve the hospital facility’s IEQ to support patient care and reduce long-term operating costs.


Next Level Medical Suffers a Data Breach

To date, NLM has no evidence of identity theft or fraud related to this event.


Extreme Weather: The Maintenance-Resilience Link

Extreme heat serves as stress test of the resilience of utility systems that provide power, cooling and life safety functions.


Encompass Health Lower Providence Opens in Pennsylvania

The 50-bed inpatient rehabilitation hospital is the company's 11th location in Pennsylvania.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.